Andere Sprachen Omnicell, Inc.

Aktien

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 18.04.2024			% 5 Tage	% 1. Jan.
27.25 ^USD	+3.73%		-0.26%	-27.58%

16.04.	Omnicell, Inc. kündigt XT Amplify an	CI
29.02.	Omnicell, Inc. kündigt Veränderungen in der Geschäftsführung an	CI

Omnicell Announces XT Amplify	16.04.
Omnicell, Inc. Announces XT Amplify	16.04.
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024	08.04.
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum	11.03.
Omnicell, Inc. Announces Executive Changes	29.02.
Omnicell Fiscal Q4 Non-GAAP Net Income Flat, Revenue Falls; Sets Outlook	08.02.
Omnicell: Q4 Earnings Snapshot	08.02.
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results	08.02.
(OMCL) OMNICELL Sees Q1 Revenue Range $232M - $242M	08.02.
(OMCL) OMNICELL Expects Fiscal Year 2024 EPS Range $0.90 - $1.40	08.02.
Earnings Flash (OMCL) OMNICELL Reports Q4 Revenue $258.8M, vs. Street Est of $255.6M	08.02.
Omnicell, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	08.02.
Omnicell, Inc. Provides Earnings Guidance for the First Quarter and Full Fiscal Year 2024	08.02.
Earnings Flash (OMCL) OMNICELL Posts Q4 EPS $0.33, vs. Street Est of $0.15	08.02.
Omnicell, Inc. Reports Unaudited Impairment Changes Results for the Fourth Quarter Ended December 31, 2023	08.02.
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024	16.01.
Omnicell Elects Eileen Voynick to Board of Directors	11.01.
Omnicell, Inc. Announces Board Changes	11.01.
Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference	27.11.
North American Morning Briefing : Stocks Look to -2-	06.11.

Keine Ergebnisse zu dieser Suche